From Gates Notes: A Conceived Blood-Based Diagnostic Test for Alzheimer's
A quiet revolution is unfolding in Alzheimer’s research—one that could change how we detect the disease long before memory loss begins. As Bill Gates writes in Gates Notes , the FDA’s approval of a blood‑based diagnostic marks a turning point: a simple test that can identify Alzheimer’s up to twenty years before symptoms appear. This breakthrough, supported by the Diagnostics Accelerator initiative he helped fund, moves diagnosis out of the realm of invasive spinal taps and costly scans and into routine, accessible screening. It’s a glimpse of a future where early detection means earlier care, and where families can face Alzheimer’s with foresight instead of fear. Read Gates Notes for more information. post inspired by Breakthrough Alzheimer's Care by Mark Wilson. Book Description Breakthrough Alzheimer's Care offers a powerful and practical roadmap for family caregivers who want more than just survival-they want their loved ones to thrive. When lea...